Methyl salicylate/menthol topical - Futura Medical
Alternative Names: SPR-300Latest Information Update: 30 Oct 2021
At a glance
- Originator Futura Medical
- Class Anti-inflammatories; Cyclohexanols; Monoterpenes; Non-opioid analgesics; Salicylates
- Mechanism of Action Cyclooxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes - Pain
Highest Development Phases
- No development reported Pain
Most Recent Events
- 28 Jul 2018 No recent reports of development identified for phase-I development in Pain(In volunteers) in United Kingdom (Topical, Gel)
- 14 Jul 2015 Futura Medical completes a phase I trial with three topical NSAID products in Pain (volunteers) in United Kingdom
- 30 Mar 2015 Methyl salicylate/menthol topical - Futura Medical is available for licensing as of 01 Jul 2013. http://www.futuramedical.com/